S
Sarah Larney
Researcher at Université de Montréal
Publications - 174
Citations - 6497
Sarah Larney is an academic researcher from Université de Montréal. The author has contributed to research in topics: Population & Medicine. The author has an hindex of 31, co-authored 152 publications receiving 4447 citations. Previous affiliations of Sarah Larney include University of New South Wales & Brown University.
Papers
More filters
Journal ArticleDOI
Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review
Louisa Degenhardt,Amy Peacock,Samantha Colledge,Janni Leung,Jason Grebely,Peter Vickerman,Jack Stone,Evan B Cunningham,Adam Trickey,Kostyantyn Dumchev,Michael T. Lynskey,Paul Griffiths,Richard P. Mattick,Matthew Hickman,Sarah Larney +14 more
TL;DR: A global multistage systematic review of sharing of equipment used for injecting drug use (IDU) identified evidence of IDU in more countries than in 2008, with the new countries largely consisting of low-income and middle-income countries in Africa.
Journal ArticleDOI
Global statistics on alcohol, tobacco and illicit drug use: 2017 status report
Amy Peacock,Amy Peacock,Janni Leung,Sarah Larney,Sarah Larney,Samantha Colledge,Matthew Hickman,Juergen Rehm,Gary A. Giovino,Robert West,Wayne Hall,Wayne Hall,Paul Griffiths,Robert Ali,Linda Gowing,John Marsden,Alize J. Ferrari,Alize J. Ferrari,Alize J. Ferrari,Jason Grebely,Michael Farrell,Louisa Degenhardt +21 more
TL;DR: In 2015 alcohol use and tobacco smoking use between them cost the human population more than a quarter of a billion disability-adjusted life years, with illicit drugs costing further tens of millions.
Journal ArticleDOI
Global patterns of opioid use and dependence: harms to populations, interventions, and future action.
Louisa Degenhardt,Jason Grebely,Jack Stone,Matthew Hickman,Peter Vickerman,Brandon D.L. Marshall,Julie Bruneau,Frederick L. Altice,Graeme Henderson,Afarin Rahimi-Movaghar,Sarah Larney +10 more
TL;DR: Opioid agonist treatment can be highly effective in reducing illicit opioid use and improving multiple health and social outcomes, by reducing overall mortality and key causes of death, including overdose, suicide, HIV, hepatitis C virus, and other injuries.
Journal ArticleDOI
Global, regional, and country-level coverage of interventions to prevent and manage HIV and hepatitis C among people who inject drugs: a systematic review
Sarah Larney,Amy Peacock,Janni Leung,Samantha Colledge,Matthew Hickman,Peter Vickerman,Jason Grebely,Kostyantyn Dumchev,Paul Griffiths,Lindsey A Hines,Evan B Cunningham,Richard P. Mattick,Michael T. Lynskey,John Marsden,John Strang,Louisa Degenhardt +15 more
TL;DR: Country-level, regional, and global estimates of coverage of NSP, OST, HIV testing, ART, and condom programmes for PWID remain poor and are likely to be insufficient to effectively prevent HIV and HCV transmission.
Journal ArticleDOI
Incidence and prevalence of hepatitis C in prisons and other closed settings: Results of a systematic review and meta-analysis
Sarah Larney,Hannah Kopinski,Curt G. Beckwith,Nickolas Zaller,Don C. Des Jarlais,Holly Hagan,Josiah D. Rich,Brenda J van den Bergh,Louisa Degenhardt +8 more
TL;DR: HCV is a significant concern in detained populations, with one in four detainees anti‐HCV‐positive, and greater attention towards prevention, diagnosis, and treatment of HCV infection among detained populations is urgently required.